- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
1 new
Companies with a Value score of at least 3, ordered by Value score
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CRNA | NOK 0.66 | -6.8% | -89.9% | NOK 53.7m | NOK 2.00 | PE5.7x | E61.2% | n/a | ||
VISTN | NOK 23.70 | 1.3% | 1.3% | NOK 1.1b | n/a | PE17.1x | n/a | 4.2% | ||
AZT | NOK 14.56 | 1.4% | -51.5% | NOK 743.6m | NOK 16.00 | PE160.7x | E76.5% | n/a | ||
NAVA | NOK 24.40 | -1.2% | -36.8% | NOK 431.0m | NOK 37.00 | PE22x | E29.6% | n/a | ||
SOFTX New | NOK 0.045 | 229.4% | -97.3% | NOK 87.4m | n/a | PS57.6x | n/a | n/a |
Page 1 of 1